PMA device
DIAM Spinal Stabilization System
Companion Spine France Sas · Prosthesis, Spinous Process Spacer/Plate (NQO, Class III) · First FDA decision Dec 10, 2025, newest Dec 10, 2025Degenerative disc disease and spinal stenosis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1,332
Naming "DIAM"
MAUDE reports
1,364
Brand "DIAM", since 2015
PubMed studies
1,475
Mentioning "DIAM"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DIAM Spinal Stabilization System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- DIAM Spinal Stabilization SystemBreakthroughPMA
P240043 · Decided Dec 10, 2025 · 369 days after receipt
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of AtherosclerosisNational determinationOn the books20.22Updated Jun 10, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "DIAM", any status and sponsor, newest update first.
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruiting
Maastricht Radiation OncologyAcademic, hospital or other
NCT06087718 · 10 participants (planned) · Start Aug 27, 2024 · Primary completion Oct 6, 2025
Device: Maastro applicator · For: Rectal Cancer; Feasibility; Toxicity and 5 more
Sites: Maastricht, Netherlands
Menoufia UniversityAcademic, hospital or other
NCT07947550 · 50 participants (planned) · Start Dec 2026 · Primary completion Dec 2027
Device: pulse oximeter to measure Perfusion Index (PI) · For: Cesarean Delivery Under Neuraxial Anesthesia
Sites: Alexandria, Egypt
- Predictors of Successful Office Operative Hysteroscopy Using a Mini-ResectoscopeActive, not recruiting
Shaare Zedek Medical CenterAcademic, hospital or other
NCT07875985 · 50 participants (planned) · Start Nov 1, 2026 · Primary completion Nov 1, 2027
Device: Office Operative Hysteroscopy Using the Karl Storz Mini-Resectoscope Without Anesthesia · For: Retained Products of Conception; Hysteroscopy; Endometrial Polyp Benign and 9 more
Sites: Jerusalem, Israel
1,329 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DIAM", and for the whole product code for context.
This brand
1,364 reports: 571 malfunction, 793 injury, 0 death
Whole product code NQO
2,342 reports: 1,410 malfunction, 926 injury, 1 death
Newest reports for this brand
- BURR, STRAIGHT, 19.5MM DIAM. 2.0 MMMalfunction
1220246-2026-05082 · Received Oct 8, 2026 · Event dated Sep 18, 2026
Device type: Orthopedic Manual Surgical Instrument (LXH)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BURR, STRAIGHT, 19.5MM DIAM. 2.0 MMMalfunction
1220246-2026-05062 · Received Oct 7, 2026 · Event dated Sep 17, 2026
Device type: Orthopedic Manual Surgical Instrument (LXH)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
0009613348-2026-015312 · Received Oct 1, 2026 · Event dated Sep 2, 2026
Device type: Implant, Endosseous, Root-Form (DZE)
Device problem as coded: Loss of Osseointegration
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DIAM"[tiab]. The summary above synthesizes these.
- AFP-DIAM Score to Predict Survival in Patients with Hepatocellular Carcinoma Before TACE: A French Multicenter Study.
Rebillard E, De Abreu N, Buchard B, et al. · Dig Dis Sci · 2024Multicenter Study
- Diaphragm muscle: a pump that can not fail.
Sieck GC, Fogarty MJ · Physiol Rev · 2025Review, Research Support, N.I.H., Extramural
- Amiodarone-induced aseptic meningitis.
Janssens L, Van Daele W, Schotsmans K · BMJ Case Rep · 2026Case Reports
- Drug-induced aseptic meningitis.
Hopkins S, Jolles S · Expert Opin Drug Saf · 2005Review
- Drug-induced aseptic meningitis: a mini-review.
Yelehe-Okouma M, Czmil-Garon J, Pape E, et al. · Fundam Clin Pharmacol · 2018Review
- Trimethoprim-sulfamethoxazole-induced aseptic meningitis.
Wambulwa C, Bwayo S, Laiyemo AO, et al. · J Natl Med Assoc · 2005Case Reports
- Evaluation of DIAMࡊ Spinal Stabilization System for lower lumbar disc degenerative disease: A randomized, prospective, single-site study.
Boody BS, Smucker JD, Sasso W, et al. · J Orthop · 2020
- Hypoxic bronchodilation.
Wetzel RC, Herold CJ, Zerhouni EA, et al. · J Appl Physiol (1985) · 1992
- Drug-induced aseptic meningitis after amoxicillin use.
Bai J, Cutler T · JAAPA · 2025Case Reports
- Trimethoprim-sulfamethoxazole induced aseptic meningitis case report.
Pata G, Montagna M, Bosi E, et al. · Medicine (Baltimore) · 2023Case Reports
- Clinical outcome following DIAM implantation for symptomatic lumbar internal disk disruption: a 3-year retrospective analysis.
Lu K, Liliang PC, Wang HK, et al. · J Pain Res · 2016
- Identification of eupneic breathing using machine learning.
Khurram OU, Mantilla CB, Sieck GC · J Neurophysiol · 2024Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code NQO.
- Superion Indirect Decompression SystemBoston Scientific Neuromodulation · PMA 2024
- coflex® Interlaminar TechnologyCompanion Spine France · PMA 2026
- X-Stop Interspinous Spacer SystemMedtronic Sofamor Danek, Inc. · PMA 2012
- Superion Interspinous SpacerBoston Scientific Neuromodulation · PMA 2017
- coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2021
- X Stop Interspinous Process Decompression SystemMedtronic Sofamor Danek, Inc. · PMA 2006
- Paradigm Spine Coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2018
- X-Stop LtosMedtronic Sofamor Danek, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.